These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 201086)

  • 41. Epstein-Barr virus induced differentiation of early B-lineage cells.
    Kubagawa H; Burrows PD; Grossi CE; Cooper MD
    Curr Top Microbiol Immunol; 1986; 132():246-50. PubMed ID: 3024917
    [No Abstract]   [Full Text] [Related]  

  • 42. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
    Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
    AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel approach to establishing permanent lymphoblastoid cell lines: Epstein-Barr virus transformation of cryopreserved lymphocytes.
    Louie LG; King MC
    Am J Hum Genet; 1991 Mar; 48(3):637-8. PubMed ID: 1847792
    [No Abstract]   [Full Text] [Related]  

  • 44. Viral latency and transformation: the strategy of Epstein-Barr virus.
    Klein G
    Cell; 1989 Jul; 58(1):5-8. PubMed ID: 2546674
    [No Abstract]   [Full Text] [Related]  

  • 45. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus persistence and virus-associated tumours.
    Niedobitek G; Young LS
    Lancet; 1994 Feb; 343(8893):333-5. PubMed ID: 7905149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of n-butyrate on transformation of human lymphocytes by Epstein-Barr virus.
    Roubalová K; Roubal J
    Intervirology; 1985; 23(1):51-4. PubMed ID: 2982760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sample age and Epstein-Barr virus transformation of cryopreserved lymphocytes.
    Reidy JA; Wheeler VA
    In Vitro Cell Dev Biol; 1992 Jun; 28A(6):383-4. PubMed ID: 1321805
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of Epstein-Barr virus in human B cell malignancies.
    Bornkamm GW
    Haematologica; 1987; 72(6 Suppl):67-70. PubMed ID: 2832280
    [No Abstract]   [Full Text] [Related]  

  • 50. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
    Wilson G; Miller G
    Virology; 1979 Jun; 95(2):351-8. PubMed ID: 223286
    [No Abstract]   [Full Text] [Related]  

  • 51. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.
    Miyazaki I; Cheung RK; Dosch HM
    J Exp Med; 1993 Aug; 178(2):439-47. PubMed ID: 8393476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus infection of cryopreserved umbilical cord blood lymphocytes.
    Shope TC; Sell MK; Smith ST; Peterson WD; Stulberg CS
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):326-9. PubMed ID: 202978
    [No Abstract]   [Full Text] [Related]  

  • 53. Epstein-Barr virus: a ubiquitous agent that can immortalize cells.
    Smith RD
    Hum Pathol; 1993 Mar; 24(3):233-4. PubMed ID: 8384157
    [No Abstract]   [Full Text] [Related]  

  • 54. Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus.
    Lucas KG; Burton R; Heilman DK; Pollok K; Emanuel D
    J Hematother; 1997 Dec; 6(6):587-90. PubMed ID: 9483194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regions of the EBV genome involved in latency and lymphocyte immortalization.
    Miller G
    Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
    [No Abstract]   [Full Text] [Related]  

  • 56. [Molecular mechanisms of establishment and disruption of Epstein-Barr virus latency].
    Takada K
    Tanpakushitsu Kakusan Koso; 1989 Jun; 34(7):823-34. PubMed ID: 2552500
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of Epstein-Barr virus to transform fetal human spleen cells for HLA typing.
    Mandel TE; Tait BD
    Transplantation; 1984 Oct; 38(4):436-7. PubMed ID: 6093295
    [No Abstract]   [Full Text] [Related]  

  • 58. Variation in expression of mouse erythrocyte receptors on Epstein-Barr virus-induced B-cell lines.
    Youinou PY; Walker PR; Irving WL; Lydyard PM
    Immunol Lett; 1984; 8(1):27-32. PubMed ID: 6086504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epstein-Barr virus. Chance and felicity.
    Galloway J
    Nature; 1989 Apr; 338(6215):463-4. PubMed ID: 2538759
    [No Abstract]   [Full Text] [Related]  

  • 60. Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus.
    Thorley-Lawson DA; Strominger JL
    Virology; 1978 May; 86(2):423-31. PubMed ID: 208257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.